Showing 2541-2550 of 9124 results for "".
Julius Few: "If I could…"
https://practicaldermatology.com/topics/practice-management/julius-few-if-i-could-/19086/If he could buy any one laser or energy based device for his practice, Julius Few, MD says he would invest in another device he already owns! Learn what he had to say and what his experience has been.Harmony XL, Dr. Manjoney
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/harmony-xl-dr-manjoney-/19236/Laser skin treatment, Harmony XL. Dr. Manjoney tells us why her patients love the Harmony XL from Alma Lasers. http://www.AlmaLasers.comSpectra VRM II Tattoo Removal
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/tattoo-removal/19524/Description of pulse duration and wavelength for chromophores and demonstrates tattoo removal in African-American patient.ISDPA: Dr. Bhatia on JAK Inhibitors
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-jak-inhibitors/27064/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about his presentation on JAK inhibitors at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.The Role of Topical Steroids in AD
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37138/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the role of topical steroids in treating atopic dermatitis.Quality of Life and the Mental Toll of Itch
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37179/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, addresses the psychological impact of itch and how it can affect a patient’s overall quality of life.Origins of AD: Recent Advances
https://practicaldermatology.com/issues/april-2025/origins-of-ad-recent-advances/35586/This paper reviews a study by Yadev et al. and further investigates the role of transient receptor potential ankyrin 1 (TRPA1) in the pathogenesis of atopic dermatitis (AD).What's New in Atopic Dermatitis?
https://reachmd.com/programs/practical-dermatology/whats-new-in-atopic-dermatitis/33014/Emma Guttman, MD, PhD, professor and chair of dermatology at Mount Sinai, talks about the latest developments in treatments and therapies for atopic dermatitis.In-Depth From the Science of Skincare Summit
https://practicaldermatology.com/issues/january-february-2025/in-depth-from-the-science-of-skincare-summit/32979/The 2024 Science of Skincare Summit this past November again positioned itself as a pivotal event in the dermatology field, offering groundbreaking insights into the intersection of innovation, consumer trends, and evidence-based skincare. Take a closer look at some of the research.Active Vitiligo: What to Look For
https://practicaldermatology.com/series/updates-vitiligo/active-vitiligo-what-to-look-for/24156/John E. Harris, MD, founding director of the Autoimmune Therapeutics Institute at the University of Massachusetts Chan Medical School, talks with Practical Dermatology Chief Medical Editor Neal Bhatia, MD, about the clinical signs of active vitiligo.